Generics Subject To Solvay Sham Litigation Claims

By Elaine Meyer · September 17, 2010, 11:28 AM EDT

A federal judge has kept alive claims alleging generics makers Par Pharmaceutical Cos. Inc. and Paddock Laboratories Inc. engaged in sham litigation by agreeing not to release competing versions of Solvay...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

IN RE: Androgel Antitrust Litigation (No. II)

Case Number

Court

Georgia Northern

Nature of Suit

Anti-Trust

Date Filed

October 05, 2009

Recent Articles By Elaine

November 05, 2010
Astellas Targets Glenmark Over Eczema Drug
November 01, 2010
Fed. Circ. Upholds Injunction On Generic Pulmicort
October 27, 2010
Customs Improperly Classified Surgical Lamps: CIT
October 22, 2010
Sidley Advises GE Healthcare In $580M Clarient Deal
October 18, 2010
FDA Panel OKs Use Of Anemia Drugs, Despite Study
October 13, 2010
Howmedica Polymers Patents Invalid: Fed Circ.
October 07, 2010
Consumers Target J&J Unit Over Listerine Marketing
October 07, 2010
Novo Can't Shake Bid To Invalidate Prandin Patent
September 27, 2010
Novo Nordisk To Challenge Russian Competition Fine
September 27, 2010
UPS Hit With ERISA Suit Over Health Benefits